Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Childhood Hematologic Malignancy Center Treatment Team

  • Our internationally recognized pediatric hematologists/oncologists and hematopathologists are world leaders in diagnosing and treating all types of pediatric blood cancers. In addition to treating lymphomas and leukemias, our pediatric hematologists/oncologists also treat histiocytosis, which is not a form of cancer but shares some of the characteristics of cancer and is often treated by pediatric hematologist/oncologists using some of the same therapies.

    Center and Program Leadership

    Andrew E. Place, MD, PhD
    Co-Director of the Hematologic Malignancy Center (Clinical Service & Clinical Research)
    Relapsed and refractory leukemia

    Kimberly Stegmaier, MD
    Co-Director of the Hematologic Malignancy Center (Basic & Translational Research)

    Melissa Burns, MD
    Early phase trials in high risk leukemia

    Kimberly J. Davies, MD
    Non-Hodgkin's lymphoma

    Barbara A. Degar, MD
    Langerhans cell histiocytosis (LCH), hemophagocytic lymphohistiocytosis (HLH)

    Angela M. Feraco, MD, MMSc
    Hodgkin lymphoma

    Jennifer C. Kesselheim, MD, M.Ed
    All types of leukemia and lymphoma, medical education

    Jessica A. Pollard, MD
    Acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloid malignancies, myeloproliferative disorders (CML, JMML, Down’s syndrome-associated Transient Myeloproliferative Disease, and other rare myeloid disorders)

    Lewis B. Silverman, MD
    Acute lymphoblastic leukemia (ALL)

    Lynda M. Vrooman, MD
    Cancer survivorship and late effects of cancer treatment